Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 4Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 2

Sponsor Class

INDUSTRY 185OTHER 70NIH 26OTHER_GOV 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Melanoma 6Lymphoma, B-Cell 5Uveal Melanoma 4Esophageal Neoplasms 4Colorectal Neoplasms 4Recurrence 3Polycystic Ovary Syndrome 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Follicular 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER_GOV × Triple Negative Breast Neoplasms × Clear all
NCT05957939 2023-07-24

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

Ministry of Health, Saudi Arabia

Phase 1 Unknown
2 enrolled
Breast

Triple Negative Breast Neoplasms

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Sheba Medical Center

Phase 1 Unknown
30 enrolled
BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡